Health Report - Separate stories podcast Shingles vaccine could slow dementia decline
Dec 5, 2025
A new study shows the shingles vaccine might help slow dementia decline, revealing surprising benefits for cognitive health. Discussions also dive into the comparison between older and newer shingles vaccines, highlighting Shingrix’s potential advantages. The WHO outlines guidelines for using GLP-1 medications in obesity treatment, while emphasizing the need for systemic changes in food policy. Finally, updated advice emerges on contraception and mental health concerning these medications. Tune in for insightful conversations on health and well-being!
AI Snips
Chapters
Transcript
Episode notes
Shingles Vaccine Linked To Slower Cognitive Decline
- Shingles vaccination was associated with lower rates of mild cognitive impairment and slowed dementia progression in Welsh data.
- The benefit appears across pre-dementia, MCI and dementia stages and was larger in women than men.
Possible Mechanisms Behind The Benefit
- The observed effect may stem from preventing herpes zoster nerve damage or broader immune effects shared by other vaccines.
- Newer Shingrix data suggest similar or greater protective effects compared with the older live vaccine.
Talk To Your GP About Shingles Vaccination
- If you're eligible for shingles vaccination, talk to your GP about getting vaccinated.
- Vaccination can prevent painful shingles and may also reduce dementia risk or slow its progression.